Thyrotoxic Periodic Paralysis — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Thyrotoxicosis activates Na+/K+-ATPase causing intracellular potassium shift (redistributive hypokalaemia); urine K is low because renal excretion is normal
Thyrotoxic periodic paralysis is caused by excessive thyroid hormone-mediated activation of Na+/K+-ATPase, driving potassium intracellularly. This is redistributive (shift) hypokalaemia, not renal wasting – hence urine potassium is appropriately low. It is more common in Asian men. Acute treatment is cautious potassium replacement (risk of rebound hyperkalaemia as the shift reverses). Definitive treatment is correction of thyrotoxicosis. Beta-blockers (Propranolol) can also help acutely by reducing Na+/K+-ATPase activity.
Reference: Lin and Bhatt 2019 – Thyrotoxic Periodic Paralysis Review